Search results
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 4 days agoCases are “stable or uncertain” in 18 others and are likely declining in one—Oklahoma. Do Vaccines...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 3 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 4 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
FDA advises Covid vaccine makers to target new contagious strain for fall shots
NBC Universal via AOL· 4 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
Is It Too Late to Buy Novavax Stock? | The Motley Fool
The Motley Fool· 3 days agoNovavax (NVAX -4.32%) stock is suddenly a buy again this year, with its stock price more than...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 6 days agoThe Sanofi partnership removes a lot of the risk associated withNovavax stock and should help the...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 3 days agoNovavax. Just be aware that the bullishness only goes so far. The consensus analyst price target on the healthcare stock is $17.50, which is only about...
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial...
Benzinga· 6 hours agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio TWLO. On June...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 7 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...